@article{443ffcbb4e584d5a9d1e8ad3b9a50524,
title = "Correction to: Molecular targeted drugs resistance impairs double-strand break repair and sensitizes ER-positive breast cancer to PARP inhibitors (Breast Cancer, (2022), 29, 1, (77-91), 10.1007/s12282-021-01282-5)",
abstract = "In the original publication of the article, the funding information should be revised as below. Funding This study was supported by AstraZeneca K.K., Ministry of Education, Culture, Sports, Science and Technology of Japan, and Smoking Research Foundation.",
author = "Yuna Suzuki and Wu Wenwen and Tomohiko Ohta and Hayashi, {Shin ichi}",
note = "Funding Information: Funding This study was supported by AstraZeneca K.K., Ministry of Education, Culture, Sports, Science and Technology of Japan, and Smoking Research Foundation. Publisher Copyright: {\textcopyright} 2021, The Japanese Breast Cancer Society.",
year = "2022",
month = jan,
doi = "10.1007/s12282-021-01288-z",
language = "English",
volume = "29",
pages = "185",
journal = "Breast Cancer",
issn = "1340-6868",
publisher = "Springer Japan",
number = "1",
}
